Pelareorep is emerging as a promising treatment in difficult-to-treat cancers, igniting optimism in the medical community. The German Paul-Ehrlich-Institute approved full enrolment for Oncolytics Biotech's pancreatic cancer study combining pelareorep…
Jade Biosciences is set to present its innovative autoimmune therapies at major biotech conferences in March 2025, with appearances in Boston and Miami. The company will highlight JADE-001, focusing on…
Automated systems monitor online activity to prevent suspicious actions, which can lead to account lockouts. Excessive page views, like 80 views in 24 hours, can trigger these automated restrictions and…
Concord Biotech's stock fell sharply by 27.71% in the past week, closing at Rs 1,693.20 on the Bombay Stock Exchange. The biotech sector is highly volatile, with rumors of regulatory…
Edesa Biotech focuses on innovation in biotech, particularly in developing the inflammatory treatment paridiprubart. Research and development saw a significant investment increase, exceeding $300,000, highlighting their commitment to healthcare advancements.…
Virginia allocates $4.9 million to Project VITAL to enhance life sciences innovation. Virginia Tech leads the initiative, aiming to transform breakthrough ideas into medical advancements. Funding from the GO Virginia…
Vertex Pharmaceuticals and Moderna represent long-term investment opportunities in the biotech sector. Vertex Pharmaceuticals recently achieved FDA approval for Journavx, a non-opioid pain medication, amid the opioid crisis. Vertex continues…
The Federal Trade Commission has updated the Hart-Scott-Rodino Act requirements for mergers, creating a more complex compliance process. This revamped HSR form requires detailed disclosure, probing deeply into the potential…
IPOs offer lucrative investment opportunities in the public market. Expert guidance, like that from Donovan Jones at IPO Edge, can reveal valuable insights. Accessing IPO filings and calendars is crucial…
Legend Biotech Corporation is becoming a significant player in the healthcare sector amidst financial strain and challenges like inflation and labor shortages. The U.S. healthcare technology market is expected to…